Vissia Viglietta
Amgen (United States)(US)Codon Biosciences (India)(IN)
Publications by Year
Research Areas
Multiple Sclerosis Research Studies, Immunotherapy and Immune Responses, Diabetes and associated disorders, Polyomavirus and related diseases, Alzheimer's disease research and treatments
Most-Cited Works
- → Loss of Functional Suppression by CD4+CD25+ Regulatory T Cells in Patients with Multiple Sclerosis(2004)1,834 cited
- → Placebo-Controlled Phase 3 Study of Oral BG-12 or Glatiramer in Multiple Sclerosis(2012)1,322 cited
- → Self-antigen tetramers discriminate between myelin autoantibodies to native or denatured protein(2007)407 cited
- → Inhibition of Human CD4+CD25+high Regulatory T Cell Function(2002)261 cited
- → Antigen microarrays identify unique serum autoantibody signatures in clinical and pathologic subtypes of multiple sclerosis(2008)244 cited
- → Sustained disease-activity-free status in patients with relapsing-remitting multiple sclerosis treated with cladribine tablets in the CLARITY study: a post-hoc and subgroup analysis(2011)243 cited